vs
Side-by-side financial comparison of INSEEGO CORP. (INSG) and STEM, INC. (STEM). Click either name above to swap in a different company.
INSEEGO CORP. is the larger business by last-quarter revenue ($48.4M vs $47.1M, roughly 1.0× STEM, INC.). INSEEGO CORP. runs the higher net margin — 1.0% vs -33.9%, a 34.9% gap on every dollar of revenue. On growth, INSEEGO CORP. posted the faster year-over-year revenue change (0.6% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 13.6%).
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
INSG vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $47.1M |
| Net Profit | $469.0K | $-16.0M |
| Gross Margin | 42.2% | 48.9% |
| Operating Margin | 2.7% | -17.7% |
| Net Margin | 1.0% | -33.9% |
| Revenue YoY | 0.6% | -15.6% |
| Net Profit YoY | 182.9% | 68.8% |
| EPS (diluted) | $-0.02 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $47.1M | ||
| Q3 25 | $45.9M | $38.2M | ||
| Q2 25 | $40.2M | $38.4M | ||
| Q1 25 | $31.7M | $32.5M | ||
| Q4 24 | $48.1M | $55.8M | ||
| Q3 24 | $54.0M | $29.3M | ||
| Q2 24 | $51.6M | $34.0M | ||
| Q1 24 | $37.5M | $25.5M |
| Q4 25 | $469.0K | $-16.0M | ||
| Q3 25 | $1.4M | $-23.8M | ||
| Q2 25 | $507.0K | $202.5M | ||
| Q1 25 | $-1.6M | $-25.0M | ||
| Q4 24 | $-566.0K | $-51.1M | ||
| Q3 24 | $9.0M | $-148.3M | ||
| Q2 24 | $624.0K | $-582.3M | ||
| Q1 24 | $-4.5M | $-72.3M |
| Q4 25 | 42.2% | 48.9% | ||
| Q3 25 | 41.6% | 35.5% | ||
| Q2 25 | 41.1% | 33.4% | ||
| Q1 25 | 47.3% | 32.4% | ||
| Q4 24 | 37.3% | -4.4% | ||
| Q3 24 | 34.8% | 21.2% | ||
| Q2 24 | 36.4% | 27.6% | ||
| Q1 24 | 35.3% | -95.0% |
| Q4 25 | 2.7% | -17.7% | ||
| Q3 25 | 4.7% | -33.6% | ||
| Q2 25 | 3.2% | -34.8% | ||
| Q1 25 | -1.3% | -65.0% | ||
| Q4 24 | 3.7% | -84.4% | ||
| Q3 24 | 1.9% | -493.2% | ||
| Q2 24 | 3.6% | -1705.5% | ||
| Q1 24 | -7.9% | -267.0% |
| Q4 25 | 1.0% | -33.9% | ||
| Q3 25 | 3.1% | -62.2% | ||
| Q2 25 | 1.3% | 527.8% | ||
| Q1 25 | -5.0% | -76.9% | ||
| Q4 24 | -1.2% | -91.6% | ||
| Q3 24 | 16.6% | -506.3% | ||
| Q2 24 | 1.2% | -1712.6% | ||
| Q1 24 | -11.9% | -283.9% |
| Q4 25 | $-0.02 | $-4.40 | ||
| Q3 25 | $0.03 | $-2.84 | ||
| Q2 25 | $-0.03 | $-1.79 | ||
| Q1 25 | $-0.16 | $-0.15 | ||
| Q4 24 | $0.62 | $-15.29 | ||
| Q3 24 | $-0.06 | $-18.24 | ||
| Q2 24 | $-0.02 | $-71.81 | ||
| Q1 24 | $-0.44 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.9M | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-4.0M | $-249.4M |
| Total Assets | $93.8M | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.9M | $48.9M | ||
| Q3 25 | $14.6M | $43.1M | ||
| Q2 25 | $13.2M | $40.8M | ||
| Q1 25 | $35.1M | $58.6M | ||
| Q4 24 | $39.6M | $56.3M | ||
| Q3 24 | $12.0M | $75.4M | ||
| Q2 24 | $49.0M | $89.6M | ||
| Q1 24 | $12.3M | $112.8M |
| Q4 25 | $-4.0M | $-249.4M | ||
| Q3 25 | $-7.7M | $-235.7M | ||
| Q2 25 | $-10.5M | $-214.1M | ||
| Q1 25 | $-13.0M | $-417.5M | ||
| Q4 24 | $-12.9M | $-398.4M | ||
| Q3 24 | $-85.1M | $-344.1M | ||
| Q2 24 | $-101.8M | $-203.2M | ||
| Q1 24 | $-105.6M | $371.6M |
| Q4 25 | $93.8M | $308.9M | ||
| Q3 25 | $85.8M | $362.6M | ||
| Q2 25 | $83.1M | $379.2M | ||
| Q1 25 | $93.0M | $405.1M | ||
| Q4 24 | $100.0M | $437.4M | ||
| Q3 24 | $113.4M | $537.8M | ||
| Q2 24 | $149.6M | $691.5M | ||
| Q1 24 | $122.1M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.0M | $8.2M |
| Free Cash FlowOCF − Capex | $11.6M | — |
| FCF MarginFCF / Revenue | 24.0% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 25.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.0M | $8.2M | ||
| Q3 25 | $3.2M | $11.4M | ||
| Q2 25 | $-4.5M | $-21.3M | ||
| Q1 25 | $-3.5M | $8.5M | ||
| Q4 24 | $-14.2M | $-14.7M | ||
| Q3 24 | $14.8M | $-9.4M | ||
| Q2 24 | $27.6M | $-11.9M | ||
| Q1 24 | $5.2M | $-621.0K |
| Q4 25 | $11.6M | — | ||
| Q3 25 | $3.1M | — | ||
| Q2 25 | $-4.7M | — | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $-14.3M | — | ||
| Q3 24 | $14.8M | — | ||
| Q2 24 | $27.6M | — | ||
| Q1 24 | — | — |
| Q4 25 | 24.0% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | -11.6% | — | ||
| Q1 25 | -11.0% | — | ||
| Q4 24 | -29.7% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | 53.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 25.50× | — | ||
| Q3 25 | 2.22× | — | ||
| Q2 25 | -8.81× | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.65× | — | ||
| Q2 24 | 44.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
